Editorial: Probiotic bacteria-derived effector molecules and their impact on the host in health and disease
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic-ecollection
Typ dokumentu úvodníky
PubMed
36523843
PubMed Central
PMC9745304
DOI
10.3389/fmicb.2022.1089461
Knihovny.cz E-zdroje
- Klíčová slova
- Bifidobacterium, Lactobacillus, exopolysaccharides, peptidoglycan, post-biotics, probiotics, vesicles,
- Publikační typ
- úvodníky MeSH
Department of Molecular Sciences Swedish University of Agricultural Sciences Uppsala Sweden
Institute of Specific Prophylaxis and Tropical Medicine Medical University of Vienna Vienna Austria
Laboratory of Gnotobiology Institute of Microbiology of the Czech Academy of Sciences Prague Czechia
Editorial on the Research Topic Probiotic bacteria-derived effector molecules and their impact on the host in health and disease PubMed
Zobrazit více v PubMed
Lebeer S., Bron P. A., Marco M. L., Van Pijkeren J. P., O'Connell Motherway M., Hiil C., et al. . (2018). Identification of probiotic effector molecules: present state and future perspectives. Curr. Opin. Biotechnol. 49, 217–223. 10.1016/j.copbio.2017.10.007 PubMed DOI
Pyclik M., Srutkova D., Schwarzer M., Gorska S. (2020). Bifidobacteria cell wall-derived exo-polysaccharides, lipoteichoic acids, peptidoglycans, polar lipids, and proteins - their chemical structure and biological attributes. Int. J. Biol. Macromol. 147, 333–349. 10.1016/j.ijbiomac.2019.12.227 PubMed DOI
Tlaskalova-Hogenova H., Stěpánková R., Kozáková H., Hudcovic T., Vannucci L., Tučková L., et al. . (2011). The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell. Mol. Immunol. 8, 110–120. 10.1038/cmi.2010.67 PubMed DOI PMC